Effects of Recombinant Human Growth Hormone Treatment, Depending on the Therapy Start in Different Nutritional Phases in Paediatric Patients with Prader–Willi Syndrome: A Polish Multicentre Study

Recombinant human growth hormone (rhGH) treatment is an established management in patients with Prader–Willi syndrome (PWS), with growth promotion and improvement in body composition and possibly the metabolic state. We compared anthropometric characteristics, insulin-like growth factor 1 (IGF1) lev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lecka-Ambroziak, Agnieszka, Wysocka-Mincewicz, Marta, Doleżal-Ołtarzewska, Katarzyna, Zygmunt-Górska, Agata, Wędrychowicz, Anna, Żak, Teresa, Noczyńska, Anna, Birkholz-Walerzak, Dorota, Stawerska, Renata, Hilczer, Maciej, Obara-Moszyńska, Monika, Rabska-Pietrzak, Barbara, Gołębiowska, Elżbieta, Dudek, Adam, Petriczko, Elżbieta, Szalecki, Mieczysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305342/
https://www.ncbi.nlm.nih.gov/pubmed/34300343
http://dx.doi.org/10.3390/jcm10143176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305342/
https://www.ncbi.nlm.nih.gov/pubmed/34300343
http://dx.doi.org/10.3390/jcm10143176

Ejemplares similares